Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial. [electronic resource]
Producer: 19760602Description: 1-9 p. digitalISSN:- 0340-5354
- Adult
- Aged
- Aromatic Amino Acid Decarboxylase Inhibitors
- Benserazide -- administration & dosage
- Blood Pressure -- drug effects
- Clinical Trials as Topic
- Drug Therapy, Combination
- Female
- Humans
- Hydrazines -- administration & dosage
- Levodopa -- administration & dosage
- Male
- Middle Aged
- Movement Disorders -- chemically induced
- Nausea -- chemically induced
- Parkinson Disease -- drug therapy
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.